ArticleCellular and molecular life sciences : CMLS2025
Sequestosome-1/p62 Mediates TLR4-Induced Inflammatory Program in Dendritic Cells Under Normoxic and Hypoxic Conditions.
Article in Cellular and molecular life sciences : CMLS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sequestosome-1/p62, a multifunctional adaptor protein, plays a critical role in NFκB signaling. In response to Toll-like receptor 4 (TLR4) activation, p62 facilitates NFκB activation via its interaction with RIP1, a process dependent on the p62 ZZ-domain. Dendritic cells (DCs), key mediators of immune responses, express a diverse array of TLRs, and their activation triggers DC maturation and pro-inflammatory cytokine secretion, including IL-1β, through NFκB signaling. Given that DCs encounter varying oxygen tensions during their lifespan, their adaptability to hypoxia is crucial. We previously demonstrated that p62 contributes to DC survival under hypoxic stress, through its crosstalk with ERK1/2. Here, we investigated the role of p62 in lipopolysaccharide (LPS)-induced inflammatory responses in DCs exposed to both normoxic and hypoxic environments. Our findings revealed that LPS induces p62 overexpression and enhanced its interaction with RIP1, regardless of oxygen levels. Furthermore, pharmacological inhibition of p62 ZZ-domain, using XRK3F2, significantly attenuated p62/RIP1 interaction, resulting in diminished NFκB activation and IL-1β production. These results highlight p62 as a critical regulator of TLR4-mediated inflammatory program in DCs in either physiological or pathological microenvironments and thus suggesting novel therapeutic targets in inflammation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.